{"id":"https://openalex.org/W2428442425","doi":null,"title":"The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.","display_name":"The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.","publication_year":2006,"publication_date":"2006-05-01","ids":{"openalex":"https://openalex.org/W2428442425","mag":"2428442425","pmid":"https://pubmed.ncbi.nlm.nih.gov/16724647"},"language":"en","primary_location":{"id":"pmid:16724647","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16724647","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of supportive oncology","raw_type":"Case Reports"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002599922","display_name":"Mario E. Lacouture","orcid":"https://orcid.org/0000-0002-4818-3710","observed_orcids":["https://orcid.org/0000-0002-4818-3710"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mario E Lacouture","raw_affiliation_strings":["Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA. m-lacouture@northwestern.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA. m-lacouture@northwestern.edu","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044364847","display_name":"Surendra Basti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Surendra Basti","raw_affiliation_strings":["Ophthalmology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033948459","display_name":"Jyoti D. Patel","orcid":"https://orcid.org/0000-0002-7550-2094","observed_orcids":["https://orcid.org/0000-0002-7550-2094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jyoti Patel","raw_affiliation_strings":["Medicine, Hematology Oncology Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Hematology Oncology Division","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029706633","display_name":"Al B. Benson","orcid":"https://orcid.org/0000-0001-5485-7227","observed_orcids":["https://orcid.org/0000-0001-5485-7227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Al Benson","raw_affiliation_strings":["Medicine, Hematology Oncology Division"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine, Hematology Oncology Division","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.0722,"has_fulltext":false,"cited_by_count":86,"citation_normalized_percentile":{"value":0.98462976,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"4","issue":"5","first_page":"236","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9010000228881836},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9350000023841858},{"id":"https://openalex.org/keywords/drug-induced-rash","display_name":"drug rash","score":0.5860000252723694},{"id":"https://openalex.org/keywords/papulopustular-eruption","display_name":"papulopustular eruption","score":0.7749999761581421},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.4620000123977661},{"id":"https://openalex.org/keywords/doxycycline","display_name":"doxycycline","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pimecrolimus","display_name":"pimecrolimus","score":0.9909999966621399},{"id":"https://openalex.org/keywords/topical-therapy","display_name":"topical treatment","score":0.4620000123977661},{"id":"https://openalex.org/keywords/multidisciplinary-clinic","display_name":"multidisciplinary clinic","score":0.5289999842643738},{"id":"https://openalex.org/keywords/facial-rash","display_name":"facial rash","score":0.335999995470047},{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9479914307594299},{"id":"https://openalex.org/C2776028589","wikidata":"https://www.wikidata.org/wiki/Q417489","display_name":"Pimecrolimus","level":4,"score":0.8459591865539551},{"id":"https://openalex.org/C2778847519","wikidata":"https://www.wikidata.org/wiki/Q7133233","display_name":"Papulopustular","level":4,"score":0.835382342338562},{"id":"https://openalex.org/C2778544681","wikidata":"https://www.wikidata.org/wiki/Q1075671","display_name":"Glabella","level":3,"score":0.8144363164901733},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7235891819000244},{"id":"https://openalex.org/C2779881321","wikidata":"https://www.wikidata.org/wiki/Q82714","display_name":"Chin","level":2,"score":0.5871515274047852},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.5309576392173767},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5055780410766602},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.48604804277420044},{"id":"https://openalex.org/C2910795874","wikidata":"https://www.wikidata.org/wiki/Q53811606","display_name":"Burning Sensation","level":2,"score":0.47022294998168945},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3659626245498657},{"id":"https://openalex.org/C2780446394","wikidata":"https://www.wikidata.org/wiki/Q41055","display_name":"Forehead","level":2,"score":0.3264385461807251},{"id":"https://openalex.org/C2778081122","wikidata":"https://www.wikidata.org/wiki/Q831530","display_name":"Rosacea","level":3,"score":0.29499149322509766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2525678277015686},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.11472433805465698},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.09588748216629028},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.07571306824684143},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.0},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003880","descriptor_name":"Dermatology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003880","descriptor_name":"Dermatology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003880","descriptor_name":"Dermatology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004318","descriptor_name":"Doxycycline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004318","descriptor_name":"Doxycycline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004318","descriptor_name":"Doxycycline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007400","descriptor_name":"Interprofessional Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007400","descriptor_name":"Interprofessional Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007400","descriptor_name":"Interprofessional Relations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008495","descriptor_name":"Medical Oncology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009885","descriptor_name":"Ophthalmology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009885","descriptor_name":"Ophthalmology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009885","descriptor_name":"Ophthalmology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012017","descriptor_name":"Referral and Consultation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012017","descriptor_name":"Referral and Consultation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012017","descriptor_name":"Referral and Consultation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16724647","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16724647","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of supportive oncology","raw_type":"Case Reports"},{"id":"mag:2428442425","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16724647","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":null,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.44999998807907104}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1968151389","https://openalex.org/W1972119499","https://openalex.org/W1982765644","https://openalex.org/W1997785599","https://openalex.org/W2046063159","https://openalex.org/W2049484790","https://openalex.org/W2090359261","https://openalex.org/W2151979638","https://openalex.org/W2163592822","https://openalex.org/W2405151655"],"related_works":["https://openalex.org/W2011513069","https://openalex.org/W2163592822","https://openalex.org/W2151979638","https://openalex.org/W2100842180","https://openalex.org/W2090359261","https://openalex.org/W2144648936","https://openalex.org/W1975426795","https://openalex.org/W2058992264","https://openalex.org/W2160344439","https://openalex.org/W2142564546","https://openalex.org/W1998085563","https://openalex.org/W2114578638","https://openalex.org/W2157036179","https://openalex.org/W2138297714","https://openalex.org/W2068523641","https://openalex.org/W1968151389","https://openalex.org/W1959598232","https://openalex.org/W54318999","https://openalex.org/W2080255466","https://openalex.org/W2077950012"],"abstract_inverted_index":{"options":[0],"with":[1,122,193,208],"the":[2,18,27,32,79,143,146,150,154,158,180,199],"patient,":[3],"erlotinib":[4,25,224],"was":[5,47,56,120,136,166,205],"initiated":[6,121],"at":[7,168],"150":[8],"mg":[9,125],"daily":[10,127],"as":[11],"a":[12,70,108,137,169,173],"single":[13],"agent.":[14],"Three":[15],"days":[16,23,55],"after":[17,24],"onset":[19],"of":[20,40,69,110,116,191],"rash":[21],"(7":[22],"initiation),":[26],"primary":[28],"hematology/oncology":[29],"team":[30,106],"called":[31],"SERIES":[33,105,174],"(Skin":[34],"and":[35,42,52,59,64,76,81,99,128,145,162,186],"Eye":[36],"Reactions":[37],"to":[38,221],"Inhibitors":[39],"EGFR":[41,111],"kinaseS)":[43],"Clinic.":[44],"The":[45,104,164],"patient":[46,165,181],"scheduled":[48],"for":[49,61],"an":[50,187],"appointment":[51],"within":[53],"2":[54],"thoroughly":[57],"evaluated":[58],"screened":[60],"other":[62],"skin":[63],"eye":[65],"conditions.":[66],"She":[67,204],"complained":[68],"burning":[71,147],"sensation":[72,148],"on":[73,78,93,142,149,157,198,223],"her":[74,94,209],"face":[75,159,200],"pruritus":[77,141],"scalp":[80,144],"upper":[82],"body.":[83],"On":[84],"physical":[85],"exam,":[86],"confluent":[87],"erythematous":[88,196],"perifollicular":[89],"pustules":[90],"were":[91],"observed":[92],"glabella,":[95],"nose,":[96],"nasolabial":[97],"folds,":[98],"chin":[100],"(Figure":[101,201],"1,":[102,202],"left).":[103],"made":[107],"diagnosis":[109],"inhibitor\u2013induced":[112],"papulopustular":[113],"cutaneous":[114],"reaction":[115],"moderate":[117],"intensity.":[118],"Therapy":[119],"doxycycline":[123],"50":[124],"twice":[126],"topical":[129],"pimecrolimus":[130],"(Elidel).":[131],"Within":[132],"5\u20137":[133],"days,":[134],"there":[135],"marked":[138],"decrease":[139],"in":[140,211],"face.":[151],"In":[152],"addition,":[153],"pustular":[155],"lesions":[156],"became":[160],"crusted":[161],"dry.":[163],"seen":[167],"2-week":[170],"follow-up":[171],"by":[172],"Clinic":[175],"dermatologist.":[176],"At":[177],"this":[178],"time,":[179],"reported":[182],"no":[183],"facial":[184],"tenderness,":[185],"exam":[188],"showed":[189],"resolution":[190],"pustules,":[192],"only":[194],"residual":[195],"macules":[197],"right).":[203],"very":[206],"satisfied":[207],"improvement":[210],"appearance":[212],"and,":[213],"more":[214],"importantly,":[215],"that":[216],"she":[217],"would":[218],"be":[219],"able":[220],"continue":[222],"ther-":[225]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}